# SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy

> **NCT05344690** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 180 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **GENETIC:** SLMAP and EPO genetic polymorphism

## Key facts

- **NCT ID:** NCT05344690
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05344690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05344690, "SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05344690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*